Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring

January 2009
Orphanet Journal of Rare Diseases;2009, Vol. 4, p21
Academic Journal
No abstract available.


Related Articles

  • Multimodality imaging for pre-clinical assessment of Fabry's cardiomyopathy. Madonna, Rosalinda; Cevik, Cihan; Cocco, Nino // European Heart Journal - Cardiovascular Imaging;Oct2014, Vol. 15 Issue 10, p1094 

    Anderson Fabry’s disease (AFD) is a rare but underdiagnosed intracellular lipid disorder which can cause left ventricular hypertrophy (LVH). Pre-clinical diagnosis of Fabry’s disease is important as it permits early stratification for enzyme replacement therapy, improving the...

  • Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy? Waldek, Stephen; Feriozzi, Sandro // BMC Nephrology;2014, Vol. 15 Issue 1, p1 

    Fabry disease is a rare, X-linked, lysosomal storage disease caused by mutations in the gene encoding the enzyme alpha-galactosidase A. Complete or partial deficiency in this enzyme leads to intracellular accumulation of globotriaosylceramide (Gb3) and related glycosphingolipids in many cell...

  • Could patient who is 'tired all the time' have lupus? Wynne-Jones, Melanie // Pulse;11/10/2003, Vol. 63 Issue 45, p72 

    Details the pathology of lupus disease. Symptoms of the disease; Diagnosis of the disease; Available treatments.

  • A Single Lung Transplant in a Patient with Fabry Disease: Causality or Far-Fetched? A Case Report. Gaggl, Martina; Kain, Renate; Jaksch, Peter; Haider, Dominik; Mundigler, Gerald; Voigtländer, Till; Sunder-Plassmann, Raute; Rommer, Paulus; Klepetko, Walter; Sunder-Plassmann, Gere // Case Reports in Transplantation;2013, p1 

    Introduction. Fabry disease is a rare X-linked lysosomal storage disorder, characterized by an α-galactosidase A deficiency resulting in globotriaosylceramide storage within cells. Subsequently, various organ systems are involved, clinically the most important are kidneys, the heart, and the...

  • Current diagnosis and management of left main coronary disease Chikwe, Joanna; Kim, Michael; Goldstone, Andrew B.; Fallahi, Arzhang; Athanasiou, Thanos // European Journal of Cardio-Thoracic Surgery;Oct2010, Vol. 38 Issue 4, p420 

    Summary: Left main coronary artery (LMCA) disease remains an important risk factor for increased mortality and morbidity at all stages of diagnosis and treatment of coronary artery disease. Left main stem pathology is often silent, with unpredictable presentation: as such it poses diagnostic and...

  • Fabry Disease: an Unusual Cause of Severe Coronary Disease in a Young Man. Fisher, Edward A.; Desnick, Robert J.; GOrdon, Ronald E.; Eng, Christine M.; Griepp, Randall; Goldman, Martin E. // Annals of Internal Medicine;8/1/92, Vol. 117 Issue 3, p221 

    Presents a case study of Fabry disease in a 27-year-old man. Background on the metabolic disorder; Medical history of the patient; Diagnosis and treatment of the disease.

  • Less Frustation. Frederick, Larry // Cortlandt Forum;4/25/2005, Vol. 18 Issue 4, p4 

    Focuses on the pathology of the disease, fibromyalgia. Symptomatology; Treatment of the disease; Diagnosis.

  • Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy. Desnick, Robert J.; Brady, Roscoe; Barranger, John; Collins, Allan J.; Germain, Dominique P.; Goldman, Martin; Grabowski, Gregory; Packman, Seymour; Wilcox, William R. // Annals of Internal Medicine;2/18/2003, Vol. 138 Issue 4, p338 

    Provides clinical guidelines on the diagnosis and treatment of Fabry disease, an X-linked recessive lysosomal storage disorder. Disease pathophysiology; Clinical manifestations; Clinical trials of enzyme replacement therapy in patients with Fabry disease; Recommendations for diagnosis and...

  • How to improve the early diagnosis of Fabry's disease? Grünfeld, Jean-Pierre // Kidney International;Sep2003, Vol. 64 Issue 3, p1136 

    Editorial. Focuses on the methods used for the diagnosis of a lysosomal disorder known as Fabry's disease. Reasons for the difficulty in early diagnosis of the disease; Symptoms of the disease; Treatment options available for the disease.

  • Renal complications of Fabry disease in children. Najafian, Behzad; Mauer, Michael; Hopkin, Robert; Svarstad, Einar // Pediatric Nephrology;May2013, Vol. 28 Issue 5, p679 

    Fabry disease is an X-linked α-galactosidase A deficiency, resulting in accumulation of glycosphingolipids, especially globotriaosylceramide, in cells in different organs in the body. Renal failure is a serious complication of this disease. Fabry nephropathy lesions are present and progress...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics